Smither John W sold NAMS
September 4, 2026 · Form 4 insider transaction
Smither John W sold 1,600 shares of NewAmsterdam Pharma Company N.V. at $25.32 per share, a transaction worth $40.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 5 days after the transaction.
Footnotes
Reported transaction reflects a sale of ordinary shares to generate proceeds to satisfy the Reporting Person's tax obligations in connection with the prior vesting of restricted stock units.; The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.24 to $25.37 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction.; Includes 8,040 ordinary shares subject to restricted stock unit awards that remain subject to vesting.